Cambia Health Solutions and Livongo Team Up on Chronic Health Conditions

Cambia Health Solutions (Cambia) and Livongo Health (Livongo) today announced a strategic partnership that combines Cambia’s vision to redesign health and health care to be more consumer-driven with Livongo’s proven ‘whole person’ approach to empowering people with chronic conditions to live better and healthier lives.

Cambia and Livongo will collaborate to personalize health care for people who have ongoing health needs in simple, meaningful and tangible ways. Initially, the companies will work together to make Livongo’s category-leading Livongo for Diabetes solution available to Regence Blue Cross and Blue Shield in Idaho, Oregon, Utah, and Washington. The companies will then expand their partnership to co-develop solutions that personalize care for conditions such as hypertension and integrated behavioral health to improve consumers’ lives nationwide.

“We see great potential in collaborating with Livongo to transform the experience Americans have in health and in sickness,” said Mark Ganz, President and Chief Executive Officer of Cambia Health Solutions. “Livongo is a kindred spirit on our journey to make health care more person-focused and economically sustainable. Both companies are committed to a human-centered design approach and seamless experiences for individuals and their families.”

Livongo Chief Executive Officer Glen Tullman commented, “At Livongo we create personalized member experiences based on data insights that we offer to our members in a way that empowers them to  make better health decisions. We’re energized by the opportunity to partner with Cambia and expand the reach and impact of our ‘whole person’ approach to health and health care.”

As part of the partnership, Echo Health Ventures, the digital health investment company jointly owned by Cambia and Mosaic Health Solutions, has made a strategic investment in Livongo. “Echo Health Ventures’ investment in Livongo recognizes the rapid success of the company’s diabetes and hypertension offerings and reflects our commitment to invest in and support solutions that personalize care for people with chronic conditions,” said Rob Coppedge, Chief Executive Officer of Echo Health Ventures.

Chronic conditions account for the largest and fastest growing part of U.S. health care costs[1] and are responsible for 7 of 10 health related deaths each year. Diabetes and hypertension are among the most prevalent of these conditions. The total estimated cost of diagnosed diabetes in 2017 was $327 billion, including $237 billion in direct medical costs and $90 billion in reduced productivity, according to a 2018 paper by the American Diabetes Association. Additionally, 1 in 5 adults in the U.S. have a mental health condition, 56% of which receive no treatment.